Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report

Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report

A 59-year-old Japanese woman was admitted for evaluation of muscle weakness. Autosomal dominant polycystic kidney disease had been diagnosed at the age of 47 years, followed by primary aldosteronism at 53 years. At the age of 58, tolvaptan was started (60 mg/day) to treat her renal disease. After 8...

Full description

Bibliographic Details
Main Authors: Kyohei Kunizawa, Junichi Hoshino, Hiroki Mizuno, Tatsuya Suwabe, Keiichi Sumida, Masahiro Kawada, Masayuki Yamanouchi, Akinari Sekine, Noriko Hayami, Rikako Hiramatsu, Eiko Hasegawa, Naoki Sawa, Kenmei Takaichi, Shigeru Shibata, Yoshifumi Ubara
Format: Article
Language:English
Published: Karger Publishers 2018-03-01
Series:Case Reports in Nephrology and Dialysis
Subjects:
Tolvaptan
Autosomal dominant polycystic kidney disease
Primary aldosteronism
Online Access:https://www.karger.com/Article/FullText/487921

Internet

https://www.karger.com/Article/FullText/487921

Similar Items